What is PT-141 (Bremelanotide)?
PT-141, also called Bremelanotide, is a synthetic peptide that activates melanocortin receptors (MC3R and MC4R) in the central nervous system. It increases sexual arousal in both men and women through a brain-level pathway, not a vascular one like Viagra or Cialis. Approved by the FDA in 2019 as Vyleesi for premenopausal women with low sexual desire.
PT-141 was originally developed from Melanotan II — the tanning peptide — when researchers noticed unexpected arousal as a side effect. They isolated the receptor activity responsible and built a cleaner analog with the libido effect without the skin pigmentation.
How does PT-141 actually work?
PT-141 acts on the central nervous system, not the blood vessels. The pathway:
- Binds melanocortin receptors MC3R and MC4R in the hypothalamus
- Triggers downstream dopamine release in arousal-related brain regions
- Effect kicks in 1–4 hours after dosing, peaks around 1.5–3 hours
- Independent of testosterone, estrogen, or local blood flow — so it works in cases where PDE5 inhibitors (Viagra, Cialis) dont
This is why PT-141 helps with arousal disorders that have a neurological or psychological root rather than just vascular function. It can complement other peptides — see our BPC-157 guide for tissue repair or our broader profiles for other use cases.
What dose does PT-141 use?
- Subcutaneous injection (standard research dose): 1.0–2.0 mg, 1–2 hours before activity
- Vyleesi (FDA approved): 1.75 mg subcutaneous, on-demand
- Nasal spray (older formulation, discontinued): 7–20 mg per dose due to lower bioavailability
Subcutaneous is the standard for research use. Reconstitute the lyophilized peptide with bacteriostatic water — same procedure as other peptides, covered in our peptide reconstitution guide.
How long does PT-141 take to work?
Onset is slower than PDE5 inhibitors. Plan for 2–6 hours before peak effect, with effects lasting 6–10 hours depending on dose and individual response. Some users report next-day residual arousal at higher doses.
This makes PT-141 less of an on-demand drug than Viagra and more of a planned-evening peptide.
What are the most common side effects?
- Nausea — by far the most common, especially in the first hour after injection. Roughly 40% of users report it in the Vyleesi trials. Mild to moderate, fades as the peptide clears.
- Facial flushing — temporary, cosmetic, no clinical significance
- Headache — usually mild, dose-dependent
- Increased blood pressure — transient ~5 mmHg rise in systolic. Not recommended if you have uncontrolled hypertension or cardiovascular disease.
- Decreased appetite — melanocortin-mediated, usually mild
- Hyperpigmentation — much less than Melanotan II but still possible with frequent dosing
Can men use PT-141?
Yes. PT-141 works in both sexes via the same central pathway. It is currently only FDA-approved for women (as Vyleesi), but the clinical data on male erectile response is solid and consistent. It is often used by men who dont respond to PDE5 inhibitors or who want a different onset profile.
How does PT-141 compare to Viagra or Cialis?
- Mechanism: PT-141 = central (brain), Viagra/Cialis = peripheral (blood vessels)
- Onset: PT-141 = 2–6 hours, Viagra = 30–60 minutes, Cialis = 30–120 minutes
- Duration: PT-141 = 6–10 hours, Viagra = 4–6 hours, Cialis = up to 36 hours
- Works for non-vascular causes: PT-141 yes, Viagra/Cialis no
- Affects desire/arousal: PT-141 yes, Viagra/Cialis no (only mechanical)
The two work differently and arent direct substitutes. PT-141 is sometimes used alongside a PDE5 inhibitor when both pathways are relevant.
How often can PT-141 be used?
Vyleesi labelling allows up to 8 doses per month, no more than one in 24 hours. Heavier or more frequent use raises the risk of melanocortin-related side effects (pigmentation, nausea, blood pressure). PT-141 is built for on-demand use, not daily dosing.
Who should not use PT-141?
- Anyone with uncontrolled high blood pressure or cardiovascular disease
- Pregnant or breastfeeding women
- People with a history of melanoma (melanocortin pathway concern)
- Anyone on medications that significantly lower blood pressure (compounding risk)
How is PT-141 stored?
- Lyophilized vial (before mixing): Refrigerated 2–8°C, stable 2+ years
- Reconstituted (mixed with bac water): Refrigerated, use within 4–6 weeks
- Light protection: Keep in original vial or amber container
Sources
- FDA label and approval data for Vyleesi (Bremelanotide), AMAG Pharmaceuticals 2019
- Pfaus et al. — melanocortin receptor activation and central arousal pathways (Pharmacology Biochemistry and Behavior)
- Diamond et al. — PT-141 clinical trials in male erectile response (Journal of Sexual Medicine)